 immunogenet predict pulmonari fibrosi system sclerosi system sclerosi patient pulmonari fibrosi autoantibodi mhc class II gene patient pulmonari fibrosi hla vs patient pulmonari fibrosi presenc rel risk develop pulmonari fibrosi patient scleroderma risk substanti care monitor patient treatment earli stage diseas